236 related articles for article (PubMed ID: 2884701)
1. [5-aminosalicylic acid treatment of ulcerative colitis during the acute phase in patients resistant or intolerant to salazopyrine].
Cappello M; Puleo A; Calabrese A; Cipolla C; Orlando A; Gatto G; Oliva L; Cottone M
Recenti Prog Med; 1987 Feb; 78(2):76-8. PubMed ID: 2884701
[No Abstract] [Full Text] [Related]
2. [Exacerbation of ulcerative colitis and the appearance of extraintestinal manifestations after salazopyrine administration].
Larrañaga JR; Mardomingo P
Med Clin (Barc); 1984 Feb; 82(6):282-3. PubMed ID: 6142990
[No Abstract] [Full Text] [Related]
3. Treatment of ulcerative colitis with oral 5-aminosalicylic acid including patients with adverse reactions to sulfasalazine.
Habal FM; Greenberg GR
Am J Gastroenterol; 1988 Jan; 83(1):15-9. PubMed ID: 2892391
[TBL] [Abstract][Full Text] [Related]
4. Salazopyrin and its newer analogues in the treatment of inflammatory bowel disease.
Banatwala N
J Pak Med Assoc; 1985 Mar; 35(3):64-8. PubMed ID: 2860256
[No Abstract] [Full Text] [Related]
5. [A new case of hypersensitivity pneumopathy caused by salazopyrine?].
Laurent K; De Jonghe M; Flemale A; Kimbimbi P; Defrance P; Gillard C
Rev Pneumol Clin; 1985; 41(5):340-3. PubMed ID: 2869567
[TBL] [Abstract][Full Text] [Related]
6. Hypersensitivity to 5-aminosalicylic acid in patients with ulcerative colitis.
Niv Y
Isr J Med Sci; 1987 Nov; 23(11):1161-3. PubMed ID: 3436802
[No Abstract] [Full Text] [Related]
7. Adverse effects of sulfasalazine and treatment of ulcerative colitis with mesalazine.
Nakajima H; Munakata A; Yoshida Y
J Gastroenterol; 1995 Nov; 30 Suppl 8():115-7. PubMed ID: 8563870
[TBL] [Abstract][Full Text] [Related]
8. [Erythema multiforme, ulcerative colitis and salazopyrine].
Garcia e Silva L
Acta Med Port; 1986; 7(2):71-2. PubMed ID: 2889320
[No Abstract] [Full Text] [Related]
9. The short- and long-term safety of 5-aminosalicylate products in the treatment of ulcerative colitis.
Baker DE; Kane S
Rev Gastroenterol Disord; 2004; 4(2):86-91. PubMed ID: 15185719
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic effectiveness and tolerance of 5-aminosalicylic acid in short term treatment of patients with ulcerative colitis at a low or medium phase of activity.
Bresci G; Carrai M; Venturini G; Gambardella L
Int J Tissue React; 1990; 12(4):243-6. PubMed ID: 1980911
[TBL] [Abstract][Full Text] [Related]
11. Comparable efficacy of oral 5-aminosalicylic acid (Mesasal) and sulfasalazine in maintaining ulcerative colitis in remission.
Eliakim R; Wengrower D; Ligumsky M; Rachmilewitz D
Isr J Med Sci; 1990 Jan; 26(1):47-9. PubMed ID: 1968895
[No Abstract] [Full Text] [Related]
12. [Successful acute treatment of chronic inflammatory intestinal diseases with oral 5-aminosalicylic acid].
Maier K; Frühmorgen P; Bode JC; Heller T; von Gaisberg U; Klotz U
Dtsch Med Wochenschr; 1985 Mar; 110(10):363-8. PubMed ID: 2857633
[TBL] [Abstract][Full Text] [Related]
13. Lung and skin hypersensitivity to 5-aminosalicylic acid.
le Gros V; Saveuse H; Lesur G; Brion N
BMJ; 1991 Apr; 302(6782):970. PubMed ID: 1827746
[No Abstract] [Full Text] [Related]
14. [Acute pancreatitis caused by salazopyrine. An unusual association].
Delgado Fontaneda E; García Campos F; Ruiz Rebollo L; Ibarra Peña B; Moretó Canela M
Rev Esp Enferm Dig; 1991 Jun; 79(6):439-40. PubMed ID: 1680357
[TBL] [Abstract][Full Text] [Related]
15. [Salazosulfapyridine or 5-aminosalicylic acid].
van Hees PA
Ned Tijdschr Geneeskd; 1987 May; 131(22):931-4. PubMed ID: 2885762
[No Abstract] [Full Text] [Related]
16. [Colitis and drug-induced lupus: the role of salazopyrine].
Rouleau L; Ménard H; Beaudry R; Myhal D
Union Med Can; 1980 Sep; 109(9):1326-30. PubMed ID: 6110262
[No Abstract] [Full Text] [Related]
17. [Efficacy and tolerability of 5-aminosalicylic acid in the short-term treatment of ulcerative rectocolitis during the mild or moderate stage].
Bresci G; Carrai M; Venturini G; Gambardella L
Minerva Dietol Gastroenterol; 1990; 36(1):31-3. PubMed ID: 1970855
[TBL] [Abstract][Full Text] [Related]
18. [Treatment of chronic inflammatory intestinal diseases with 5-aminosalicylic acid].
Malchow H
Internist (Berl); 1987 Jan; 28(1):14-20. PubMed ID: 2883152
[No Abstract] [Full Text] [Related]
19. [Exacerbation of ulcerative colitis and Crohn's disease following a change-over from salazosulfapyridine to 5-aminosalicylic acid].
Feurle GE; Helmstädter V
Dtsch Med Wochenschr; 1986 May; 111(18):721-2. PubMed ID: 2870908
[No Abstract] [Full Text] [Related]
20. The value of 5-aminosalicylic acid in inflammatory bowel disease for patients intolerant or allergic to sulphasalazine.
Donald IP; Wilkinson SP
Postgrad Med J; 1985 Dec; 61(722):1047-8. PubMed ID: 2869480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
